Hematopoietic Stem Cell Transplantation + Total Body Irradiation + Cyclophosphamide + Mycophenolate Mofetil + Tacrolimus for graft vs host disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Feb 2011: Trial started, NCT01349101
  2. 6 May 2011: Trial registered, NCT01349101

The trials

NCT01349101: A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

State
Completed
Phase
Phase 2
People
78 taking part
Started
10 Feb 2011
Primary completion
31 Oct 2022
Arms
Myeloablative HSCT
Results
Posted on the registry
  1. 10 Feb 2011: Trial started
  2. 6 May 2011: Trial registered
  3. 7 Dec 2022: Trial completed
  4. 15 Dec 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.